UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027055
Receipt number R000031014
Scientific Title Validation study for effect of Hydrogen Coral Powder (Pure Ash Coral) to ammonia in the blood
Date of disclosure of the study information 2017/04/19
Last modified on 2017/04/18 22:56:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Validation study for effect of Hydrogen Coral Powder (Pure Ash Coral) to ammonia in the blood

Acronym

Validation study for effect of Hydrogen Coral Powder (Pure Ash Coral) to ammonia in the blood

Scientific Title

Validation study for effect of Hydrogen Coral Powder (Pure Ash Coral) to ammonia in the blood

Scientific Title:Acronym

Validation study for effect of Hydrogen Coral Powder (Pure Ash Coral) to ammonia in the blood

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We investigate the effect of health food "Hydrogen Coral Powder (Pure Ash Coral)" to ammonia in the blood in healthy adults.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Intake method: 2g daily
Intake period: 3 months
Test point: 0 week, 2 weeks, 2 months, 3
months
Measuring method: Blood test

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Period: 3 months
Test food: Hydrogen Coral Powder (Pure Ash Coral)
Dose: Intake 2g of Hydrogen Coral Powder a day
Usage: Intake 1g of Hydrogen Coral Powder with
water before meal (breakfast and dinner)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

Not under 40 years old when giving consent.
Critical hepatic dysfunction and/or critical renal dysfunction not to be observed at screening test.
Person who give first-person consent in writing.

Key exclusion criteria

Person who are obviously not able to visit hospital during the trial.
Person whom doctor-in-charge judges the one is unsuitable for this trial.

Target sample size

3


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Koji Yano

Organization

First Co.,Ltd.

Division name

Director

Zip code


Address

5-7-14, Kitashinagawa, Shinagawa-ku, Tokyo

TEL

03-5475-8967

Email

info@suiso1st.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Makiko Ido

Organization

First Co.,Ltd.

Division name

Planning Office

Zip code


Address

5-7-14, Kitashinagawa, Shinagawa-ku, Tokyo

TEL

03-5475-8967

Homepage URL


Email

info@suiso1st.co.jp


Sponsor or person

Institute

First Co.,Ltd.

Institute

Department

Personal name



Funding Source

Organization

First Co.,Ltd.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

クリニック真健庵(東京)


Other administrative information

Date of disclosure of the study information

2017 Year 04 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 12 Month 13 Day

Date of IRB


Anticipated trial start date

2016 Year 01 Month 25 Day

Last follow-up date

2016 Year 04 Month 27 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 04 Month 18 Day

Last modified on

2017 Year 04 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031014


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name